First Clinical Use of Robotic Tissue Balancing with OMNIBotics Technology

By Julie A. Vetalice

OMNIlife science announced the first clinical use of novel robotic tissue balancing with the OMNIBotics® robotic-assisted total knee replacement platform, occurring in Australia.

The OMNIBotics system, based on proprietary ART™ software (APEX Robotic Technology), has been used globally in >13,000 procedures to date, supporting patient-specific procedures and eliminating the need for pre-op CT scans or x-rays.

OMNIBotics has approval under the CE Mark; a 510(k) has been submitted to FDA for U.S. clearance.

Sources: OMNIlife science, Inc.; ORTHOWORLD Inc.

Product Labels: Knee Replacement, Robot-Assisted Systems

Tags: Product Launch